BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

LTB4 as a therapy for influenza A infection

Elizabeth S. Eaton
May 28, 2019 5:57 PM UTC

INDICATION: Influenza virus ...

BCIQ Company Profiles

Mcgill University

BCIQ Target Profiles

Leukotriene B4 (LTB4)

Leukotriene B4 type 1 receptor (BLT1) (LTB4R)

BCIQ Company Profiles

Mcgill University

BCIQ Target Profiles

Leukotriene B4 (LTB4)

Leukotriene B4 type 1 receptor (BLT1) (LTB4R)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2026 BioCentury Inc. All Rights Reserved.
Copyright © 2026 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS